Janus Zn-Mo nanozymes for leveraged trienzymatic anticancer therapy
Year: 2025
Type: article
Abstract: , with an inhibition rate of up to 95 %. These findings provide crucial insights into the atomic- and electronic-level mechanisms of DAs with varying coordination environments and further promote the deep integration of nanotechnology and biology.
Source: Materials Today Bio
Authors: Shuang Liu, Jiawei Qu, Jiating Xu, Qiang Wang, Le Zhang, Xinyu Zhang, Chunsheng Li, Yong Lu, Yi Zhong, Linbo Li, Piaoping Yang
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,400
Funders: National Natural Science Foundation of China, Northeast Forestry University, Higher Education Discipline Innovation Project, National University's Basic Research Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China Stem Cell and Translational Research
OpenAlex ID: W4417147695